About

Imported from lev-os/agents (skills-db/legal/managing-pediatric-seizures/SKILL.md). Install upstream with npx skills add lev-os/agents --skill managing-pediatric-seizures. Copyright stays with the author.

Managing Pediatric Seizures

Name: managing-pediatric-seizures
Author: lev-os

Structures the evaluation, classification, acute management, and long-term treatment of seizures in children using the ILAE 2017 classification framework, age-specific epilepsy syndrome recognition, evidence-based anticonvulsant selection, and status epilepticus protocols.

Why This Skill Exists

Seizures are the most common pediatric neurologic emergency, with febrile seizures affecting 2-5% of children and epilepsy affecting approximately 1% of the pediatric population. The ILAE 2017 three-tier classification system (seizure type → epilepsy type → epilepsy syndrome) replaced outdated terminology and drives treatment selection. Different epilepsy syndromes require different medications — some anticonvulsants worsen certain epilepsies (e.g., carbamazepine in absence epilepsy). This skill enforces proper classification, syndrome-directed therapy, and standardized status epilepticus management.

Checkpoint A — Intake Verification

Required Intake Questions

What is the child's age (determines likely seizure syndrome)?
Describe the event in detail: what was the child doing before, during (motor activity, eye deviation, cyanosis, duration), and after (postictal state)?
Was there witnessed loss of consciousness?
What is the total seizure duration? Was there clustering?
Has the child had fever? (if < 5 years, febrile seizure differential)
Is there a family history of seizures or epilepsy?
Are there developmental concerns or known neurologic conditions?
What medications is the child currently taking (including OTC and herbals)?
Was there any preceding head trauma?
If on anticonvulsants: current drug levels, recent dose changes, adherence?

Required Documents

Detailed event description (from witness/caregiver)
Vital signs including temperature at time of event
Neurologic examination findings
EEG results (if previously obtained)
Neuroimaging results (MRI preferred over CT for epilepsy workup)
Current anticonvulsant levels (if applicable)
Developmental history

Step 1 — Seizure Classification (ILAE 2017)

Level 1: Seizure Type

Category	Subtypes
Focal onset	Aware vs. impaired awareness; motor onset (automatisms, atonic, clonic, epileptic spasms, hyperkinetic, myoclonic, tonic) vs. non-motor onset (autonomic, behavior arrest, cognitive, emotional, sensory); focal to bilateral tonic-clonic
Generalized onset	Motor: tonic-clonic, clonic, tonic, myoclonic, myoclonic-tonic-clonic, myoclonic-atonic, atonic, epileptic spasms; Non-motor (absence): typical, atypical, myoclonic, eyelid myoclonia
Unknown onset	Motor: tonic-clonic, epileptic spasms; Non-motor: behavior arrest

Level 2: Epilepsy Type

Focal epilepsy
Generalized epilepsy
Combined generalized and focal epilepsy
Unknown

Level 3: Epilepsy Syndrome

Match age of onset and seizure semiology to recognized syndromes (see Step 2).

Step 2 — Common Pediatric Epilepsy Syndromes

Age-Based Syndrome Recognition

Syndrome	Age of Onset	Key Features	EEG Pattern	First-Line Treatment
Infantile spasms (West syndrome)	3-12 months	Clusters of flexion/extension spasms, developmental regression	Hypsarrhythmia	ACTH or vigabatrin (vigabatrin first-line if tuberous sclerosis)
Dravet syndrome	5-8 months	Prolonged febrile seizures, later myoclonic/absence/focal; SCN1A mutation	Generalized spike-wave	Valproate, clobazam, stiripentol, fenfluramine; AVOID Na-channel blockers
Childhood absence epilepsy (CAE)	4-10 years	Staring spells 10-30 sec with abrupt onset/offset, multiple per day	3 Hz generalized spike-wave	Ethosuximide (first-line per SANAD II), valproate, lamotrigine
Juvenile myoclonic epilepsy (JME)	12-18 years	Morning myoclonic jerks, GTC seizures; precipitated by sleep deprivation	4-6 Hz generalized polyspike-wave	Valproate (males), levetiracetam or lamotrigine (females, due to VPA teratogenicity)
Benign epilepsy with centrotemporal spikes (BECTS/Rolandic)	3-13 years	Focal motor seizures of face/mouth, often nocturnal; may not need treatment	Centrotemporal spikes activated by sleep	Observation if infrequent; levetiracetam or oxcarbazepine if treatment needed
Lennox-Gastaut syndrome	2-8 years	Multiple seizure types (tonic, atonic, atypical absence), intellectual disability	Slow (< 2.5 Hz) spike-wave, paroxysmal fast activity in sleep	Valproate, clobazam, rufinamide, lamotrigine; consider VNS, dietary therapy

Medications to AVOID by Syndrome

Syndrome	Avoid
Absence epilepsy	Carbamazepine, oxcarbazepine, phenytoin (worsen absences)
JME	Carbamazepine, oxcarbazepine, phenytoin (worsen myoclonus)
Dravet syndrome	Carbamazepine, oxcarbazepine, phenytoin, lamotrigine (worsen seizures via Na-channel blockade)

Step 3 — Febrile Seizures (Special Category)

Simple Febrile Seizure

Age 6 months to 5 years
Generalized tonic-clonic, duration < 15 minutes, does not recur within 24 hours
Temperature ≥ 38°C (100.4°F)
Normal neurologic exam after postictal period resolves
Management: no workup needed (no EEG, no imaging, no labs routinely); reassurance and antipyretic education

Complex Febrile Seizure

Focal features, duration > 15 minutes, recurrence within 24 hours, or abnormal postictal exam
Warrants: LP consideration (especially < 12 months or if meningitis suspected), EEG, possible MRI

AAP Febrile Seizure Guidance

EEG is NOT recommended after a simple febrile seizure (does not predict recurrence or epilepsy risk)
LP: perform if < 12 months with incomplete Hib/PCV vaccination; strongly consider if 12-18 months; consider if > 18 months with meningeal signs
Daily anticonvulsant prophylaxis is NOT recommended for simple febrile seizures
Recurrence risk: approximately 30% after first febrile seizure; risk factors: age < 18 months, lower temperature at seizure onset, family history

Step 4 — Acute Seizure / Status Epilepticus Protocol

Definition

Status epilepticus: seizure lasting > 5 minutes, or ≥ 2 seizures without return to baseline between episodes

Timed Protocol (Aligned with AES/NCS Guidelines)

Time Point	Action
0-5 min (stabilization)	ABCs, position, oxygen, suction, check glucose, monitor SpO2; if ≥ 5 min → treat
5-20 min (first-line)	Benzodiazepine: midazolam 0.2 mg/kg IM (max 10 mg) OR lorazepam 0.1 mg/kg IV (max 4 mg) OR diazepam 0.2-0.5 mg/kg rectal (max 20 mg); may repeat once at 5-10 min
20-40 min (second-line)	Fosphenytoin 20 mg PE/kg IV (max rate 3 mg PE/kg/min) OR levetiracetam 40-60 mg/kg IV (max 4500 mg) OR valproate 40 mg/kg IV (max 3000 mg)
40-60 min (refractory)	Repeat second-line agent if different from first OR begin continuous infusion: midazolam 0.2 mg/kg bolus → 0.05-2 mg/kg/hr
> 60 min (super-refractory)	ICU: pentobarbital, propofol (caution in children — propofol infusion syndrome), ketamine; continuous EEG monitoring

Step 5 — Chronic Anticonvulsant Selection and Monitoring

First-Line Agents by Seizure Type

Seizure Type	First-Line Options	Notes
Focal	Oxcarbazepine, levetiracetam, lamotrigine	Oxcarbazepine: watch for hyponatremia
Generalized tonic-clonic	Valproate, levetiracetam, lamotrigine	VPA: avoid in females of childbearing age if possible
Absence	Ethosuximide, valproate, lamotrigine	ESM for absence only; does not cover GTC
Infantile spasms	ACTH (high-dose, short course), vigabatrin	Vigabatrin first if tuberous sclerosis

Monitoring Requirements

Drug levels: phenytoin, phenobarbital, valproate, carbamazepine (others rarely needed)
CBC and LFTs at baseline and periodically for VPA, carbamazepine, phenytoin
VPA: monitor ammonia if lethargy develops; check for polycystic ovarian syndrome in adolescent females
Lamotrigine: titrate slowly (risk of Stevens-Johnson syndrome; increased risk with VPA co-therapy)
Levetiracetam: monitor for behavioral side effects (irritability, aggression) — common in children

Discontinuation Criteria

Consider discontinuation after 2 years seizure-free (most syndromes)
EEG before taper: normal EEG supports successful withdrawal
BECTS: may remit by mid-teens; trial off medication reasonable
JME: lifelong treatment typically required (high relapse rate off medication)

Step 6 — Diagnostic Workup

EEG

Obtain routine EEG for all new-onset unprovoked seizures (except simple febrile seizures)
Sleep-deprived EEG increases yield for generalized epilepsies (JME, CAE)
Prolonged EEG monitoring (24-72 hours) for: frequent events, diagnostic uncertainty, pre-surgical evaluation

Neuroimaging

MRI brain (epilepsy protocol with thin coronal cuts through hippocampi) for: focal seizures, abnormal neurologic exam, developmental delay, age < 1 year, refractory epilepsy
CT: only for acute presentations where MRI not immediately available (trauma, stroke, hemorrhage concern)
MRI NOT routinely needed for: simple febrile seizures, typical CAE with classic EEG, typical BECTS

Laboratory

Glucose (at time of seizure)
Electrolytes (sodium, calcium, magnesium) for first seizure
Toxicology screen if suspicion for ingestion
Genetic testing: epilepsy gene panels for refractory epilepsy, infantile-onset seizures, or syndromic features

Checkpoint B — Seizure Management Review

Quality Audit

Item	Requirement	Pass?
ILAE classification	Three-tier classification documented
Syndrome identification	Appropriate syndrome recognized or "unknown" stated
Febrile seizure protocol	Correctly classified; inappropriate workup avoided
EEG indication	Ordered when indicated; deferred with documented rationale
MRI indication	Epilepsy protocol MRI obtained for appropriate indications
Drug selection	Anticonvulsant matches seizure type; contraindicated drugs avoided
Monitoring	Drug levels, CBC, LFTs ordered per medication requirements
Status epilepticus	Timed protocol followed with appropriate escalation
Rescue medication	Prescribed with training for home/school use
No unexplained [VERIFY] tags	All flagged items resolved or escalated

Guidelines

Follow ILAE 2017 Classification of Seizures and Epilepsies for terminology and classification
Apply AAP 2011 guideline for simple febrile seizures (no routine EEG, imaging, or labs)
Follow AES/NCS 2016 guidelines for status epilepticus treatment protocol
SANAD II trial data: ethosuximide first-line for childhood absence; lamotrigine and valproate as alternatives
Infantile spasms: follow ICISS/UKISS protocols (ACTH vs. vigabatrin)
Dravet syndrome: avoid sodium-channel blockers per ILAE recommendation
Valproate: FDA teratogenicity warning — avoid in females of childbearing potential when alternatives exist
Lamotrigine: follow slow titration schedule (slower with VPA co-therapy) to reduce SJS risk
Epilepsy surgery: refer to comprehensive epilepsy center if 2 appropriate medications fail (drug-resistant epilepsy per ILAE definition)
Ketogenic diet: effective for drug-resistant epilepsy, particularly Lennox-Gastaut, GLUT1 deficiency, and tuberous sclerosis
This skill produces clinical documentation; it does not replace clinical judgment

Use it

Copy one of these into your project. Installing also returns the manifest and these snippets.

yaml

targets:
  - https://api.opensmartroute.ai/api/v1/registry/lev-os-agents-managing-pediatric-seizures/manifest   # or paste the manifest below

Manifest

An Open Capability Manifest: the router reads it to know what this does, what it costs and when to pick it.

lev-os-agents-managing-pediatric-seizures.ocm.jsonjson

{
  "ocm": "1",
  "id": "lev-os-agents-managing-pediatric-seizures",
  "kind": "skill",
  "name": "managing-pediatric-seizures",
  "description": "Structures seizure evaluation with EEG interpretation and anticonvulsant selection for pediatric populations. Use when evaluating pediatric seizures, interpreting pediatric EEGs, or selecting anticonvulsants for children.",
  "publisher": "lev-os",
  "version": "1.0.0",
  "capabilities": {
    "domains": [
      "general"
    ],
    "tags": [
      "skill-md",
      "management",
      "pediatrics",
      "valuation",
      "github"
    ],
    "languages": [
      "en"
    ]
  },
  "quality_prior": 0.6,
  "examples": [
    "Structures seizure evaluation with EEG interpretation and anticonvulsant selection for pediatric populations. Use when evaluating pediatric seizures, interpreting pediatric EEGs, or selecting anticonvulsants for children."
  ],
  "primary": false,
  "metadata": {
    "source": {
      "provider": "github",
      "repository": "https://github.com/lev-os/agents",
      "path": "skills-db/legal/managing-pediatric-seizures/SKILL.md",
      "ref": "62e97827ea88ff5dfa3efe76d19a8fa54d3da360",
      "url": "https://github.com/lev-os/agents/blob/62e97827ea88ff5dfa3efe76d19a8fa54d3da360/skills-db/legal/managing-pediatric-seizures/SKILL.md",
      "key": "lev-os/agents/skills-db/legal/managing-pediatric-seizures/SKILL.md"
    }
  },
  "instructions": "# Managing Pediatric Seizures\n\nStructures the evaluation, classification, acute management, and long-term treatment of seizures in children using the ILAE 2017 classification framework, age-specific epilepsy syndrome recognition, evidence-based anticonvulsant selection, and status epilepticus protocols.\n\n## Why This Skill Exists\n\nSeizures are the most common pediatric neurologic emergency, with febrile seizures affecting 2-5% of children and epilepsy affecting approximately 1% of the pediatric population. The ILAE 2017 three-tier classification system (seizure type → epilepsy type → epilepsy s",
  "cost": {
    "context_tokens": 3119
  }
}

Fetch it by URL: GET /api/v1/registry/lev-os-agents-managing-pediatric-seizures/manifest?version=1.0.0

Reviews

Star ratings from people who tried it. One review per account; edit yours any time.

No reviews yet. Install it, try it, and be the first to rate it.